Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KENNETH LIEBERMAN

Allopathic & Osteopathic Physicians Pediatrics Pediatric Nephrology

NPI
1174582951
CMS profile
8374
Location
HACKENSACK, NJ

General Payments · PY2018–2024

$122,212.51

  • Reported across 163 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$28,784.98

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Honoraria $17,000.00 8
Consulting Fee $8,140.00 2
Travel and Lodging $2,036.55 4
Food and Beverage $1,600.20 17
Education $8.23 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $17,939.21 31
PY2019 $9,510.80 14
PY2020 $21,128.96 23
PY2021 $5,420.83 7
PY2022 $6,089.39 14
PY2023 $33,338.34 42
PY2024 $28,784.98 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aurinia Pharma U.S., Inc. $8.23 01/12/2024 Education Undisputed 01/23/2026 1150686279 CMS
Aurinia Pharma U.S., Inc. $124.96 05/16/2024 Food and Beverage Undisputed 01/23/2026 1150686281 CMS
CALLIDITAS THERAPEUTICS US INC. $750.00 01/18/2024 Honoraria Undisputed 01/23/2026 1141508365 CMS
CALLIDITAS THERAPEUTICS US INC. $310.94 03/21/2024 Travel and Lodging Undisputed 01/23/2026 1141511827 CMS
CALLIDITAS THERAPEUTICS US INC. $121.12 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141512043 CMS
CALLIDITAS THERAPEUTICS US INC. $79.96 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141512045 CMS
CALLIDITAS THERAPEUTICS US INC. $79.96 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141512047 CMS
CALLIDITAS THERAPEUTICS US INC. $79.96 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141512049 CMS
CALLIDITAS THERAPEUTICS US INC. $79.96 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141512051 CMS
CALLIDITAS THERAPEUTICS US INC. $179.64 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141512053 CMS
CALLIDITAS THERAPEUTICS US INC. $125.00 03/27/2024 Food and Beverage Undisputed 01/23/2026 1141512439 CMS
CALLIDITAS THERAPEUTICS US INC. $3,000.00 04/04/2024 Honoraria Undisputed 01/23/2026 1141512851 CMS
CALLIDITAS THERAPEUTICS US INC. $4,500.00 04/24/2024 Honoraria Undisputed 01/23/2026 1141513875 CMS
CALLIDITAS THERAPEUTICS US INC. $1,500.00 05/30/2024 Honoraria Undisputed 01/23/2026 1141516115 CMS
CALLIDITAS THERAPEUTICS US INC. $250.00 07/03/2024 Honoraria Undisputed 01/23/2026 1141517993 CMS
CALLIDITAS THERAPEUTICS US INC. $113.96 09/17/2024 Food and Beverage Undisputed 01/23/2026 1141522229 CMS
CALLIDITAS THERAPEUTICS US INC. $913.21 09/17/2024 Travel and Lodging Undisputed 01/23/2026 1141522231 CMS
CALLIDITAS THERAPEUTICS US INC. $3,000.00 09/26/2024 Honoraria Undisputed 01/23/2026 1141523241 CMS
CALLIDITAS THERAPEUTICS US INC. $3,000.00 10/02/2024 Honoraria Undisputed 01/23/2026 1141523913 CMS
CALLIDITAS THERAPEUTICS US INC. $1,000.00 12/09/2024 Honoraria Undisputed 01/23/2026 1141529053 CMS
GENZYME CORPORATION $120.29 02/15/2024 Food and Beverage Undisputed 01/23/2026 1139644392 CMS
Novartis Pharmaceuticals Corporation $18.35 01/10/2024 Food and Beverage Undisputed 01/23/2026 1087071250 CMS
Novartis Pharmaceuticals Corporation $13.28 04/02/2024 Food and Beverage Undisputed 01/23/2026 1087071276 CMS
Novartis Pharmaceuticals Corporation $18.08 06/11/2024 Food and Beverage Undisputed 01/23/2026 1087071314 CMS
Novartis Pharmaceuticals Corporation $139.99 11/07/2024 Food and Beverage Undisputed 01/23/2026 1087071394 CMS
Novartis Pharmaceuticals Corporation $290.75 11/08/2024 Food and Beverage Undisputed 01/23/2026 1087071386 CMS
Novartis Pharmaceuticals Corporation $207.28 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1087071388 CMS
Novartis Pharmaceuticals Corporation $5,500.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1087071390 CMS
Novartis Pharmaceuticals Corporation $605.12 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1087071392 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,640.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1118837967 CMS
Travere Therapeutics, Inc. $3.52 03/06/2024 Food and Beverage Undisputed 01/23/2026 1149877256 CMS
Travere Therapeutics, Inc. $11.42 03/06/2024 Food and Beverage Undisputed 01/23/2026 1149877260 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.